UPDATE: Amneal Pharmaceuticals (AMRX) Tops Q4 EPS by 3c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus, Provides FY20 EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. INTC
9. ADBE
10. GOOGL

Go back to UPDATE: Amneal Pharmaceuticals (AMRX) Tops Q4 EPS by 3c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus, Provides FY20 EPS Outlook

Mallinckrodt Opioid Settlement an Incremental Positive for Others Exposed to Liability - RBC

February 25, 2020 12:29 PM EST

RBC analyst Randall Stanicky said Mallinckrodt's (NYSE: MNK) proposed global opioid settlement an incremental positive for others that have opioid litgation exposure, including Allergan (NYSE: AGN), Amneal Pharmaceuticals (NYSE: AMRX), Endo International... More